GeneFerm Biotechnology Co

GeneFerm Biotechnology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co (1796.TWO) as of Oct 20, 2026 is 46.04 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -35.49 M TWD — a change of -229.72% (higher).

EBITDA

46.04 MTWD

YoY

-229.72%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co is 2025 46.04 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co was 2024 -35.49 M TWD. It decreases by -229.72% higher compared to the previous year.

The GeneFerm Biotechnology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
9.82 M TWD
Jan 1, 2019
-23.38 M TWD
Jan 1, 2020
17.52 M TWD
Jan 1, 2021
79.15 M TWD
Jan 1, 2022
113.31 M TWD
Jan 1, 2023
157.18 M TWD
Jan 1, 2024
-35.49 M TWD
Jan 1, 2025
46.04 M TWD
The GeneFerm Biotechnology Co EBITDA history
YEAREBITDAYoY
46.04 MTWD-229.72%
-35.49 MTWD-122.58%
157.18 MTWD+38.71%
113.31 MTWD+43.16%
79.15 MTWD+351.80%
17.52 MTWD-174.94%
-23.38 MTWD-338.04%
9.82 MTWD-72.86%
36.19 MTWD-68.94%
116.51 MTWD+112.00%
54.96 MTWD-396.49%
-18.54 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneFerm Biotechnology Co Stock analysis

What does GeneFerm Biotechnology Co do? GeneFerm Biotechnology Co., Ltd. generates revenue through the manufacture and sale of health food and supplement products, including fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrate products. The company also offers related manufacturing services, health food design, and research and development services. Its primary customers are consumers seeking health-focused dietary supplements, with a focus on fermented and natural health food solutions. The firm targets health-conscious individuals and wellness-oriented markets through its product portfolio. The business model relies on direct sales of its branded health food products, leveraging the growing demand for natural and fermented dietary supplements. The company's R&D services support product innovation, while manufacturing services cater to partners requiring specialized production capabilities. Health food design services further enhance its offerings for clients in the wellness industry. GeneFerm's revenue streams are derived from both product sales and service-based offerings, with a strong emphasis on fermented health food solutions. The company's focus on medicinal mushrooms and lactic acid bacteria products differentiates its market position, appealing to consumers interested in natural health remedies and probiotic benefits. GeneFerm Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co is 46.04 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GeneFerm Biotechnology Co changed from -35.49 M TWD to 46.04 M TWD, representing a -229.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) GeneFerm Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s GeneFerm Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — GeneFerm Biotechnology Co

All Key Metrics — GeneFerm Biotechnology Co